Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
07/10/2025 | CALL | $799.90 | 643 | +643 | |
12/19/2025 | CALL | $1,000.00 | 1,450 | +621 | +74.91% |
07/18/2025 | CALL | $860.00 | 1,465 | +613 | +71.95% |
07/10/2025 | CALL | $779.10 | 600 | +600 | |
09/19/2025 | CALL | $780.00 | 500 | +500 | |
09/19/2025 | PUT | $780.00 | 500 | +500 | |
07/18/2025 | PUT | $780.00 | 628 | -39 | -5.85% |
07/03/2025 | CALL | $805.00 | 687 | -66 | -8.76% |
07/18/2025 | CALL | $1,000.00 | 2,206 | -76 | -3.33% |
07/18/2025 | PUT | $900.00 | 74 | -116 | -61.05% |
12/19/2025 | PUT | $500.00 | 284 | -150 | -34.56% |
07/18/2025 | CALL | $880.00 | 636 | -278 | -30.42% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
VIG Is a Popular Dividend ETF for Passive Income. But Is It the Best?
06/28 09:22 am
The Motley Fool
Read moreMicroservices in Healthcare Market Size to Hit USD 1,905.26 Million by 2032, Driven by Cloud Adoption and Healthcare Digitization – SNS Insider
06/28 08:00 am
GlobeNewswire Inc.
Read more3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
06/25 06:05 am
The Motley Fool
Read moreUnited States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption
06/25 05:56 am
GlobeNewswire Inc.
Read moreMcDonald’s Is Down, but Long-Term Investors Can Still Take a Bite
06/20 09:50 am
Investing.com
Read moreEli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition
06/17 08:07 am
Benzinga
Read moreWhy Novo Nordisk Stock Sank by Nearly 4% Today
06/16 06:21 pm
The Motley Fool
Read moreEli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
06/15 07:30 am
The Motley Fool
Read moreShould You Buy Eli Lilly Stock Before June 22?
06/11 04:23 am
The Motley Fool
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreSelective Estrogen Receptor Modulators Market Research 2025-2030: Leading Players Shaping the Future of Selective Estrogen Receptor Modulators Industry
06/09 04:56 am
GlobeNewswire Inc.
Read more5 Monster Stocks to Hold for the Next 10 Years
06/09 04:25 am
The Motley Fool
Read moreShould You Invest $1,000 in Eli Lilly today?
06/05 04:15 am
The Motley Fool
Read more2 Giants in Different Technical Stages: Eli Lilly and Broadcom
06/05 03:14 am
Investing.com
Read morePrediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027
06/04 05:12 am
The Motley Fool
Read moreHealthcare Sector Setting Up for a Catch-Up Trade in H2?
06/02 12:07 pm
Investing.com
Read moreNxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
06/01 07:30 pm
GlobeNewswire Inc.
Read moreLooking for a Blend of Growth and Dividend Stocks Amid Market Uncertainty? Consider This Low-Cost Vanguard ETF.
05/30 04:21 am
The Motley Fool
Read moreDrug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities
05/29 05:42 am
GlobeNewswire Inc.
Read moreNovo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?
05/28 04:15 am
The Motley Fool
Read moreEli Lilly's May Meltdown Is In History Books — Could June Seasonality Bring A Rebound?
05/27 03:39 pm
Benzinga
Read moreBreaking The Pain Barrier: Lilly's Acquisition Of SiteOne Aims For Opioid Alternatives
05/27 03:32 pm
Benzinga
Read moreSchizophrenia Drugs Market Research Report 2025-2035: Advances in Antipsychotic Drug Development, Increasing Prevalence, & Greater Awareness and Access to Mental Health Care Bolster Growth
05/27 10:56 am
GlobeNewswire Inc.
Read morePrurigo Nodularis Market - Global and Regional Analysis and Forecasts 2025-2035 | Advancements in Biologic Therapies Revolutionize Prurigo Nodularis Treatment
05/26 10:53 am
GlobeNewswire Inc.
Read moreIs the Vanguard Dividend Appreciation ETF a Buy Now?
05/22 04:10 am
The Motley Fool
Read moreGLP-1R Agonists Label Extensions/Drug Repurposing Market Overview 2025 | Novo Nordisk and Eli Lilly Lead, but New Entrants Eye GLP-1RA Market Opportunities
05/21 01:43 pm
GlobeNewswire Inc.
Read moreBio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption
05/19 10:56 am
GlobeNewswire Inc.
Read moreNVIDIA RTX PRO Servers Speed Trillion-Dollar Enterprise IT Industry Transition to AI Factories
05/19 12:07 am
GlobeNewswire Inc.
Read moreTrump’s Drug Pricing Order Targets PBMs—Pharma Stocks May Escape the Worst
05/16 01:35 pm
Investing.com
Read moreIs It Time to Buy the Dip in Novo Nordisk Stock?
05/15 08:29 am
Investing.com
Read moreTherini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
05/14 10:00 am
GlobeNewswire Inc.
Read morePresident Trump Just Announced Terrible News for Eli Lilly Investors
05/11 07:23 am
The Motley Fool
Read morePrediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030
05/11 06:05 am
The Motley Fool
Read moreMerus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
05/09 10:46 am
GlobeNewswire Inc.
Read more4 No-Brainer Stocks to Buy Right Now
05/09 06:30 am
The Motley Fool
Read moreOne of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years
05/08 06:05 pm
The Motley Fool
Read morePost-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy
05/08 09:05 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Surged Nearly 20% Higher in April
05/06 04:33 am
The Motley Fool
Read moreLilly declares second-quarter 2025 dividend
05/05 12:47 pm
Benzinga
Read more3 No-Brainer Stocks to Buy in May
05/05 06:45 am
The Motley Fool
Read moreIs the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
05/04 04:49 am
The Motley Fool
Read moreWall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday? (CORRECTED)
05/01 02:42 pm
Benzinga
Read moreWhy Eli Lilly Stock Is Sinking Today
05/01 12:49 pm
The Motley Fool
Read moreWhy Novo Nordisk Stock Popped Today
05/01 11:11 am
The Motley Fool
Read more1 Beaten-Down Stock to Buy and Hold for 10 Years
05/01 05:47 am
The Motley Fool
Read moreMetastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
04/30 01:00 pm
GlobeNewswire Inc.
Read moreEli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
04/30 05:50 am
The Motley Fool
Read more